Press release
Xerostomia Therapeutics Market Growing Exponentially at a CAGR of 3.5% to Surpass US$ 2,993.61 Million From 2025 to 2034
Xerostomia Therapeutics Market
Market Introduction:
Xerostomia therapeutics refers to the treatments and interventions used to manage and alleviate the symptoms of dry mouth (xerostomia), which is a condition characterized by reduced or absent saliva production. The goal is to reduce the discomfort and potential complications associated with dry mouth, such as difficulty speaking and swallowing and increased risk of dental problems. Many medications, such as antihistamines and decongestants, can reduce saliva production. The specific treatment plan for xerostomia will depend on the underlying cause and the severity of the symptoms. Early intervention and proper oral hygiene are crucial to prevent complications like dental caries and oral infections. Regular dental check-ups are important for individuals with xerostomia to monitor for any signs of dental problems.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market/request-for-sample
Growth Drivers:
• The growing incidence of chronic illnesses and the expanding elderly population globally are fueling the demand for xerostomia therapeutics solutions.
• Increasing understanding of how xerostomia affects oral health is further driving market growth.
• The increasing use of chemotherapy and radiotherapy in treating cancer is fueling the need for xerostomia therapeutics.
• Advancements in saliva substitutes and the creation of new drug formulations are aiding market expansion.
Competitive Landscape:
The xerostomia therapeutics market includes various active companies providing a selection of over-the-counter and prescription items designed to relieve xerostomia symptoms.
Major participants in the market consist of:
• Acacia Pharma
• Colgate-Palmolive Company
• Forward Science
• GlaxoSmithKline plc
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceuticals, Inc.
• Mission Pharmacal Company
• OraCoat
• Parnell Pharmaceuticals, Inc.
• Pendopharm
• Pfizer Inc.
• Recordati Industria Chimica e Farmaceutica S.p.A
• Sun Pharmaceutical Industries Ltd.
• Synedgen, Inc.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market/request-for-discount-pricing
Xerostomia Therapeutics Market Report Highlights:
• The OTC segment, based on type, dominated the xerostomia therapeutics market share in 2024 due to the widespread availability and affordability of products, offering quick relief for dry mouth symptoms. However, the prescription segment is registering the fastest growth, driven by increasing cases of chronic conditions such as Sjögren's syndrome that require specialized treatments.
• The salivary stimulants segment, by product, dominated the market share in 2024 as they are effective in stimulating saliva production, addressing the core issue of xerostomia.
• North America dominated the xerostomia therapeutics market revenue share in 2024 due to the high prevalence of xerostomia and extensive healthcare access. Asia Pacific is the fastest growing due to increasing awareness of the condition, rising healthcare infrastructure, and a growing elderly population.
Segmental Analysis:
• The xerostomia therapeutics market is globally segmented based on product, type, and region.
• The OTC segment, based on type, led the market share in 2024 due to reasons like easy access, cost-effectiveness, and greater efficiency of OTC products.
Xerostomia Therapeutics Market, Type Outlook (Revenue - USD Million, 2020-2034)
• OTC
• Prescription
Xerostomia Therapeutics Market, Product Outlook (Revenue - USD Million, 2020-2034)
• Salivary Stimulants
• Salivary Substitutes
• Dentifrices
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market
Regional Analysis:
• North America led the revenue share of the xerostomia therapeutics market in 2024, largely because of the significant occurrence of dry mouth conditions and heightened awareness campaigns.
• The market for xerostomia therapeutics in Asia Pacific is expected to experience the fastest growth due to a rise in research and development activities and a higher incidence of diabetes, cancer, and Parkinson's treatment.
• North America
o Type Outlook
• OTC
• Prescription
o Product Outlook
• Salivary Stimulants
• Salivary Substitutes
• Dentifrices
• Asia Pacific
o Type Outlook
• OTC
• Prescription
o Product Outlook
• Salivary Stimulants
• Salivary Substitutes
• Dentifrices
More Trending Latest Reports by Polaris Market Research:
FEP Heat Shrink Medical Tubing Market:
https://www.polarismarketresearch.com/industry-analysis/fep-heat-shrink-medical-tubing-market
Canine Orthopedics Market:
https://www.polarismarketresearch.com/industry-analysis/canine-orthopedics-market
Speaking Valve Market:
https://www.polarismarketresearch.com/industry-analysis/speaking-valve-market
Bio-Based Polypropylene in Medical Devices Market:
https://www.polarismarketresearch.com/industry-analysis/bio-based-polypropylene-in-medical-devices-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Xerostomia Therapeutics Market Growing Exponentially at a CAGR of 3.5% to Surpass US$ 2,993.61 Million From 2025 to 2034 here
News-ID: 3976463 • Views: …
More Releases from Polaris Market Research & Consulting
Circular Fashion Resale Platforms Market size worth USD 95.77 Billion by 2034, P …
Circular Fashion Resale Platforms Market
The global circular fashion resale platforms market is anticipated to grow significantly, according to the newly published research report by Polaris Market Research. The market was valued at USD 24.81 billion in 2024 and is projected to grow to USD 95.77 billion by 2034. This growth signifies a robust compound annual growth rate (CAGR) of 14.5% over the forecast period, 2025-2034.
Market Overview
Circular fashion resale platforms are…
Digital Detox Tourism Services Market is Expected to Grow at a CAGR of over 24.5 …
Digital Detox Tourism Services Market
The global digital detox tourism services market size was valued at USD 52.32 billion in 2024. It is anticipated to generate an estimated revenue of USD 466.58 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust CAGR of 24.5% over the forecasted timeframe, 2025 to 2034.
Market Scope
The term digital detox tourism refers to…
AI-First Product Development Tools Market Disruption Report: Emerging Trends, In …
AI-First Product Development Tools Market
The global AI-first product development tools market size was valued at USD 15.01 billion in 2024. It is anticipated to generate an estimated revenue of USD 134.77 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust CAGR of 24.60% over the forecasted timeframe, 2025 to 2034.
Market Scope
Artificial Intelligence (AI) is rapidly transforming…
Silent Luxury Goods Market is Expected to Register a CAGR of 7.3% Poised to Reac …
The silent luxury goods market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 278.13 billion by 2034 and is expected to register a CAGR of 7.3% in the above-mentioned forecast period. The market was valued at USD 137.48 billion in 2024.
Market Overview:
Silent luxury is a lifestyle defined by understated elegance and refined consumption, emphasizing exclusivity and…
More Releases for Xerostomia
Xerostomia (Dry Mouth) Therapeutics Market Opportunities, Business Statistics Re …
The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=31976
Some of the leading companies in this market include Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., Ora Health Inc., Parnell Pharmaceuticals, Inc., Ora…
Global Xerostomia (Dry Mouth) Treatment Market Segmentation and Analysis Researc …
With recorded sales worth US$ 952.7 Bn in 2021, the global xerostomia (dry mouth) treatment market is expected to experience high growth over the coming years owing to increasing consumption of prescribed medicines globally. The xerostomia treatment market is estimated to expand at a CAGR of nearly 6.1% from 2022 to 2032.
Xerostomia is commonly known as dry mouth that occurs as a result of decreased or missing saliva because of…
Xerostomia Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Xerostomia Therapeutics Market will grow with a CAGR value of 3.8 percent by 2026. Factors boosting demand growth include increasing prescription drug consumption, quick accessibility & cost-effectiveness of drugs, a rising elderly population demographic, and an uptick in the incidence of disorders such as Sjogren's syndrome, HIV, diabetes, and Alzheimer's disease, among others.
Browse 151 Market Data Tables and 111 Figures spread through…
Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027
"Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Xerostomia epidemiology and market outlook for the 7MM.
Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Xerostomia Understanding and Treatment Algorithm
The market report provides the overview of the Xerostomia by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches…
Xerostomia Market: Global Market Capacity, Production, Revenue by Regions till 2 …
Xerostomia Market report gives a far reaching investigation of the Xerostomia the Research of disease transmission, giving the chronicled and forecasted information for the 7MM during the estimate time frame from 2016-2027. The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns, it also helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Get Sample PDF of Xerostomia…
Xerostomia (Dry Mouth) Treatment Market Growth to be Stimulated by 2025
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia…
